No title
Background: Social prescribing (SP) has emerged as a non-medical strategy to enhance cancer survivors’ well-being by addressing psychosocial challenges through diverse interventions. Despite growing evidence of benefits, a comprehensive synthesis of intervention effectiveness and implementation barriers remains limited. This scoping review updates current evidence on SP interventions, outcomes, an
